3
4
5
6
TREATMENT
Topical therapy
Systemic therapy
Physical treatments
7 EPIDEMIOLOGY
8 MARKETED DRUGS
9 Approvals by country
10 PIPELINE DRUGS
11 KEY UPCOMING EVENTS
12 KEY REGULATORY EVENTS
13 Galderma Pioneers NDA Path Into OTC Acne Treatment Market
14 Indian Start-up Vyome Wins Milestone FDA Nod For Acne Studies
15 LICENSING AND ASSET ACQUISITION DEALS
16 Sato licenses Japanese rights to Novan's acne candidate SB204
17 PARENT PATENTS
18 REVENUE OPPORTUNITY
19
20
21
22
23
CLINICAL TRIAL LANDSCAPE
Sponsors by status
Sponsors by phase
Acne Pipeline Yields Three Disappointments, One Win So Far In 2017
Xenon Down On Novel Acne Treatment Failure
24 BIBLIOGRAPHY
25 Prescription information:
26 APPENDIX
LIST OF FIGURES
11
22
22
23
23
29
31
32
35
35
36
36
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
1: Trends in prevalent cases of acne, 2016–25
2: Pipeline drugs for acne in the US
3: Pipeline drugs for acne, by country
4: Pipeline drugs for acne, by drug type
5: Pipeline drugs for acne, by classifications
6: Key upcoming events in acne
7: Licensing and asset acquisition deals in acne
8: Parent patents in acne
9: Clinical trials in acne
10: Top 10 drugs for clinical trials in acne
11: Top 10 companies for clinical trials in acne
12: Trial locations in acne